Phase II NEO-MEL-T melanoma trial posts results after reaching primary completionOct 20Trial updatecobolimabdostarlimab-gxly
GSK's DREAMM 12 posts results with 36 enrolled; COSTAR Lung stays active, not recruitingJul 1Weekly roundup, 2 itemsbelantamabbelantamab mafodotin